# Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

> **NCT01348451** · PHASE1 · UNKNOWN · sponsor: **Neuralstem Inc.** · enrollment: 18 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DEVICE:** surgical implantation

## Key facts

- **NCT ID:** NCT01348451
- **Lead sponsor:** Neuralstem Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2016-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348451, "Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01348451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*